학술논문

WIPI1 is a conserved mediator of right ventricular failure
Document Type
article
Source
JCI Insight. 5(11)
Subject
Biomedical and Clinical Sciences
Medical Physiology
Cardiovascular Medicine and Haematology
Cardiovascular
Heart Disease
Genetics
2.1 Biological and endogenous factors
Aetiology
Adult
Animals
Animals
Newborn
Autophagy
Autophagy-Related Proteins
Cells
Cultured
Disease Models
Animal
Disease Progression
Female
Gene Regulatory Networks
HSP20 Heat-Shock Proteins
Heart Failure
Heart Ventricles
Humans
Male
Membrane Proteins
Microtubule-Associated Proteins
Middle Aged
Mitochondria
Myocytes
Cardiac
Oxidative Stress
Primary Cell Culture
RNA-Seq
Signal Transduction
Up-Regulation
Ventricular Dysfunction
Right
Cardiology
Cardiovascular disease
Heart failure
Molecular biology
Biomedical and clinical sciences
Health sciences
Language
Abstract
Right ventricular dysfunction is highly prevalent across cardiopulmonary diseases and independently predicts death in both heart failure (HF) and pulmonary hypertension (PH). Progression towards right ventricular failure (RVF) can occur in spite of optimal medical treatment of HF or PH, highlighting current insufficient understanding of RVF molecular pathophysiology. To identify molecular mechanisms that may distinctly underlie RVF, we investigated the cardiac ventricular transcriptome of advanced HF patients, with and without RVF. Using an integrated systems genomic and functional biology approach, we identified an RVF-specific gene module, for which WIPI1 served as a hub and HSPB6 and MAP4 as drivers, and confirmed the ventricular specificity of Wipi1, Hspb6, and Map4 transcriptional changes in adult murine models of pressure overload induced RV- versus LV- failure. We uncovered a shift towards non-canonical autophagy in the failing RV that correlated with RV-specific Wipi1 upregulation. In vitro siRNA silencing of Wipi1 in neonatal rat ventricular myocytes limited non-canonical autophagy and blunted aldosterone-induced mitochondrial superoxide levels. Our findings suggest that Wipi1 regulates mitochondrial oxidative signaling and non-canonical autophagy in cardiac myocytes. Together with our human transcriptomic analysis and corroborating studies in an RVF mouse model, these data render Wipi1 a potential target for RV-directed HF therapy.